{"id":"https://openalex.org/W3143618917","doi":"https://doi.org/10.1016/j.coph.2021.02.009","title":"Transforming targeted cancer therapy with PROTACs: A forward-looking perspective","display_name":"Transforming targeted cancer therapy with PROTACs: A forward-looking perspective","alternate_titles":[],"publication_year":2021,"publication_date":"2021-03-30","ids":{"openalex":"https://openalex.org/W3143618917","doi":"https://doi.org/10.1016/j.coph.2021.02.009","mag":"3143618917","pmid":"https://pubmed.ncbi.nlm.nih.gov/33799000"},"language":"en","primary_location":{"id":"doi:10.1016/j.coph.2021.02.009","doi":"https://doi.org/10.1016/j.coph.2021.02.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.coph.2021.02.009","pdf_url":null,"source":{"id":"https://openalex.org/S13215328","display_name":"Current Opinion in Pharmacology","issn_l":"1471-4892","issn":["1471-4892","1471-4973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3143618917"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.coph.2021.02.009","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017997902","display_name":"William Farnaby","orcid":"https://orcid.org/0000-0001-8610-932X","observed_orcids":["https://orcid.org/0000-0001-8610-932X"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"William Farnaby","raw_affiliation_strings":["Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK. Electronic address: w.farnaby@dundee.ac.uk","Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK. Electronic address: w.farnaby@dundee.ac.uk","institution_ids":["https://openalex.org/I177639307"]},{"raw_affiliation_string":"Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064523434","display_name":"Manfred Koegl","orcid":"https://orcid.org/0000-0001-6633-9769","observed_orcids":["https://orcid.org/0000-0001-6633-9769"]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"}],"raw_author_name":"Manfred Koegl","raw_affiliation_strings":["Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria. Electronic address: manfred.koegl@boehringer-ingelheim.com","Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria. Electronic address: manfred.koegl@boehringer-ingelheim.com","institution_ids":["https://openalex.org/I4210119669"]},{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042675870","display_name":"Darryl B. McConnell","orcid":"https://orcid.org/0000-0002-2537-3458","observed_orcids":["https://orcid.org/0000-0002-2537-3458"]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darryl B. McConnell","raw_affiliation_strings":["Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036373931","display_name":"Alessio Ciulli","orcid":"https://orcid.org/0000-0002-8654-1670","observed_orcids":["https://orcid.org/0000-0002-8654-1670"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alessio Ciulli","raw_affiliation_strings":["Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK","institution_ids":["https://openalex.org/I177639307"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5017997902","https://openalex.org/A5064523434"],"corresponding_institution_ids":["https://openalex.org/I177639307","https://openalex.org/I4210119669"],"apc_list":{"value":3210,"currency":"USD","value_usd":3210},"apc_paid":{"value":3210,"currency":"USD","value_usd":3210},"fwci":1.259,"has_fulltext":true,"cited_by_count":68,"citation_normalized_percentile":{"value":0.79188256,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"57","issue":null,"first_page":"175","last_page":"183"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/protacs","display_name":"PROTACs","score":0.9980000257492065},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.8330000042915344},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8339999914169312},{"id":"https://openalex.org/keywords/target-selectivity","display_name":"target selectivity","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tissue-specificity","display_name":"tissue specificity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/small-molecule-degraders","display_name":"small-molecule degraders","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6769565939903259},{"id":"https://openalex.org/C2778012447","wikidata":"https://www.wikidata.org/wiki/Q1034415","display_name":"Scope (computer science)","level":2,"score":0.6595901846885681},{"id":"https://openalex.org/C2780443040","wikidata":"https://www.wikidata.org/wiki/Q3737863","display_name":"Bifunctional","level":3,"score":0.5760492086410522},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.49012646079063416},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4862441122531891},{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.4294382631778717},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2973601818084717},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23999720811843872},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23714914917945862},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09984764456748962},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06713888049125671},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D059748","descriptor_name":"Proteolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.coph.2021.02.009","doi":"https://doi.org/10.1016/j.coph.2021.02.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.coph.2021.02.009","pdf_url":null,"source":{"id":"https://openalex.org/S13215328","display_name":"Current Opinion in Pharmacology","issn_l":"1471-4892","issn":["1471-4892","1471-4973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pharmacology","raw_type":"journal-article"},{"id":"pmid:33799000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33799000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/e64d5fd1-5817-4bed-b8e2-1f1c1fcc0446","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/e64d5fd1-5817-4bed-b8e2-1f1c1fcc0446","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Farnaby, W, Koegl, M, McConnell, D B & Ciulli, A 2021, 'Transforming targeted cancer therapy with PROTACs : A forward-looking perspective', Current Opinion in Pharmacology, vol. 57, pp. 175-183. https://doi.org/10.1016/j.coph.2021.02.009","raw_type":"info:eu-repo/semantics/review"}],"best_oa_location":{"id":"doi:10.1016/j.coph.2021.02.009","doi":"https://doi.org/10.1016/j.coph.2021.02.009","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.coph.2021.02.009","pdf_url":null,"source":{"id":"https://openalex.org/S13215328","display_name":"Current Opinion in Pharmacology","issn_l":"1471-4892","issn":["1471-4892","1471-4973"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310441","display_name":"Boehringer Ingelheim","ror":"https://ror.org/00q32j219"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3143618917.pdf","grobid_xml":"https://content.openalex.org/works/W3143618917.grobid-xml"},"referenced_works_count":89,"referenced_works":["https://openalex.org/W1764134105","https://openalex.org/W1934704664","https://openalex.org/W1971102429","https://openalex.org/W2024432096","https://openalex.org/W2043058822","https://openalex.org/W2044423100","https://openalex.org/W2053473615","https://openalex.org/W2071652604","https://openalex.org/W2115279327","https://openalex.org/W2121846636","https://openalex.org/W2137511124","https://openalex.org/W2146737519","https://openalex.org/W2146926552","https://openalex.org/W2165087323","https://openalex.org/W2227431445","https://openalex.org/W2237670736","https://openalex.org/W2286718346","https://openalex.org/W2300442403","https://openalex.org/W2420593137","https://openalex.org/W2588654455","https://openalex.org/W2597078857","https://openalex.org/W2601913258","https://openalex.org/W2605411274","https://openalex.org/W2625751604","https://openalex.org/W2734897764","https://openalex.org/W2735132087","https://openalex.org/W2739964468","https://openalex.org/W2756179047","https://openalex.org/W2761240402","https://openalex.org/W2762842128","https://openalex.org/W2767856718","https://openalex.org/W2781383440","https://openalex.org/W2787649310","https://openalex.org/W2797865989","https://openalex.org/W2805296794","https://openalex.org/W2806672448","https://openalex.org/W2806694687","https://openalex.org/W2810408973","https://openalex.org/W2883077013","https://openalex.org/W2884204281","https://openalex.org/W2888514087","https://openalex.org/W2888598609","https://openalex.org/W2899768176","https://openalex.org/W2900693695","https://openalex.org/W2901669535","https://openalex.org/W2903964626","https://openalex.org/W2909034820","https://openalex.org/W2909353434","https://openalex.org/W2912500408","https://openalex.org/W2913179893","https://openalex.org/W2914587883","https://openalex.org/W2917565897","https://openalex.org/W2923057410","https://openalex.org/W2936686072","https://openalex.org/W2944640816","https://openalex.org/W2947106191","https://openalex.org/W2948220248","https://openalex.org/W2953873379","https://openalex.org/W2963086398","https://openalex.org/W2968953400","https://openalex.org/W2969906935","https://openalex.org/W2970042698","https://openalex.org/W2974217727","https://openalex.org/W2976247988","https://openalex.org/W2980620763","https://openalex.org/W2985227205","https://openalex.org/W2986723208","https://openalex.org/W2987291349","https://openalex.org/W2987656807","https://openalex.org/W2990574223","https://openalex.org/W2990669650","https://openalex.org/W2991059836","https://openalex.org/W2992546470","https://openalex.org/W2994376311","https://openalex.org/W2994492843","https://openalex.org/W2999280110","https://openalex.org/W3008322752","https://openalex.org/W3012324425","https://openalex.org/W3013366980","https://openalex.org/W3014696958","https://openalex.org/W3019413018","https://openalex.org/W3040830058","https://openalex.org/W3047048853","https://openalex.org/W3047822086","https://openalex.org/W3084688073","https://openalex.org/W3085146133","https://openalex.org/W3110503354","https://openalex.org/W3119591201","https://openalex.org/W3127094302"],"related_works":["https://openalex.org/W4361277745","https://openalex.org/W4396956646","https://openalex.org/W3113562469","https://openalex.org/W7130580130","https://openalex.org/W4312139080","https://openalex.org/W4415320829","https://openalex.org/W4319160690","https://openalex.org/W4417147025","https://openalex.org/W4224815538","https://openalex.org/W3166285126"],"abstract_inverted_index":{"Small-molecule":[0],"targeted":[1],"protein":[2],"degraders":[3],"have":[4],"in":[5,48,91],"recent":[6],"years":[7],"made":[8],"a":[9,28],"great":[10],"impact":[11],"on":[12,31],"the":[13,32,49,60,84,98],"strategies":[14],"of":[15,51,102],"many":[16],"industry":[17],"and":[18,34,76],"academic":[19],"cancer":[20,52],"research":[21],"endeavours.":[22],"We":[23,54],"seek":[24],"here":[25],"to":[26,65,88],"provide":[27,77],"concise":[29],"perspective":[30],"opportunities":[33,95],"challenges":[35],"that":[36,58],"lie":[37],"ahead":[38],"for":[39,62],"bifunctional":[40,100],"degrader":[41],"molecules,":[42],"so-called":[43],"'Proteolysis":[44],"Targeting":[45],"Chimeras":[46],"(PROTACs),'":[47],"context":[50],"therapy.":[53],"highlight":[55],"high-profile":[56],"studies":[57],"support":[59],"potential":[61],"PROTAC":[63],"approaches":[64],"broaden":[66],"drug":[67,71],"target":[68,74],"scope,":[69],"address":[70],"resistance,":[72],"enhance":[73],"selectivity":[75],"tissue":[78],"specificity,":[79],"but":[80],"also":[81,106],"assess":[82],"where":[83],"modality":[85],"is":[86],"yet":[87],"fully":[89],"deliver":[90],"these":[92,103],"contexts.":[93],"Future":[94],"presented":[96],"by":[97],"unique":[99],"nature":[101],"molecules":[104],"are":[105],"discussed.":[107]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3143618917","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":22},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-04-13T00:00:00"}
